Serological diagnostic factors for liver metastasis in patients with colorectal cancer

World Journal of Gastroenterology

Volumn 16, Issue 32, 2010, Pages 4084-4088

  Wu, Xiong Zhi ^a   Ma, Feng ^a   Wang, Xue Lin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoembryonic antigen; Colorectal cancer; Lactate dehydrogenase; Liver metastasis; glutamyltransferase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARCINOEMBRYONIC ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SURVIVAL TIME;

EID: 77956626185     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i32.4084     Document Type: Article

References (21)

1. Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th ed. Philadelphia: Elsevier Saunders, 2005
2. Rothbarth J, van de Velde CJ. Treatment of liver metastases of colorectal cancer. Ann Oncol 2005; 16 Suppl 2: ii144-ii149
3. Paschos KA, Bird N. Current diagnostic and therapeutic approaches for colorectal cancer liver metastasis. Hippokratia 2008; 12: 132-138
4. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol 2007; 16: 3-5
5. Metcalfe MS, Bridgewater FH, Mullin EJ, Maddern GJ. Useless and dangerous--fine needle aspiration of hepatic colorectal metastases. BMJ 2004; 328: 507-508
6. Fornari F, Civardi G, Cavanna L, Di Stasi M, Rossi S, Sbolli G, Buscarini L. Complications of ultrasonically guided fineneedle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. Scand J Gastroenterol 1989; 24: 949-955
7. Smith EH. Complications of percutaneous abdominal fineneedle biopsy. Review. Radiology 1991; 178: 253-258
8. Bipat S, van Leeuwen MS, Ijzermans JN, Comans EF, Planting AS, Bossuyt PM, Greve JW, Stoker J. Evidence-base guideline on management of colorectal liver metastases in the Netherlands. Neth J Med 2007; 65: 5-14
9. Ottmar MD, Gonda RL Jr, Leithauser KJ, Gutierrez OH. Liver function tests in patients with computed tomography demonstrated hepatic metastases. Gastrointest Radiol 1989; 14: 55-58
10. Mielczarek M, Chrzanowska A, Scibior D, Skwarek A, Ashamiss F, Lewandowska K, Baranczyk-Kuzma A. Arginase as a useful factor for the diagnosis of colorectal cancer liver metastases. Int J Biol Markers 2006; 21: 40-44
11. Grotowski M. Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer] Pol Merkur Lekarski 2002; 12: 77-80
12. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003; 39: 718-727
13. Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 2008; 15: 3433-3439
14. Munjal D, Chawla PL, Lokich JJ, Zamcheck N. Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases. Cancer 1976; 37: 1800-1807
15. Baur M, Schlappack O, Havelec L, Wrba F, Dittrich C. Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer--a retrospective analysis. Acta Med Austriaca 2001; 28: 135-140
16. Díaz R, Aparicio J, Gironés R, Molina J, Palomar L, Segura A, Montalar J. Analysis of prognostic factors and applicability of Kohne's prognostic groups in patients with metastatic colorectal cancer treated with first-line irinotecan or oxaliplatin- based chemotherapy. Clin Colorectal Cancer 2005; 5: 197-202
17. Machida N, Yoshino T, Boku N, Hironaka S, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Asaka M. Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer. Jpn J Clin Oncol 2008; 38: 689-694
18. Rocklin MS, Senagore AJ, Talbott TM. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Dis Colon Rectum 1991; 34: 794-797
19. Bakalakos EA, Burak WE Jr, Young DC, Martin EW Jr. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Am J Surg 1999; 177: 2-6
20. Tartter PI, Slater G, Gelernt I, Aufses AH Jr. Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase. Ann Surg 1981; 193: 357-360
21. Steele L, Cooper EH, Mackay AM, Losowsky MS, Goligher JC. Combination of carcinoembryonic antigen and gamma glutamyl transpeptidase in the study of the evolution of colorectal cancer. Br J Cancer 1974; 30: 319-324